InfuSystem Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on November 12, 2019, by InfuSystem Holdings, Inc. (the "Company"), a Delaware corporation. The report discloses the entry into a material definitive agreement on November 7, 2019, specifically the Sixth Amendment to the Company's Credit Agreement with JPMorgan Chase Bank, N.A.
Key Financial Metrics and Debt Structure
The filing details significant modifications to the Company's debt facilities rather than reporting operational financial results such as revenue or profit. Key debt metrics include:
- Capital Expenditure Loan Commitment: A new commitment of $10,000,000 was added to the existing $8,000,000 commitment, available for drawing until December 31, 2020, for eligible equipment purchases (up to 90% of hard costs).
- Revolving Commitment: Increased to $11,750,000.
- Term Loan Restructuring: Term A, Term B, and Term C loans were refinanced into a single Term Loan.
- Maturity Dates: The Revolving Credit and Term Loan maturity dates were extended to five years from the amendment effective date.
Material Changes Versus Prior Period
The primary material change is the amendment of the Credit Agreement originally entered into on March 23, 2015. Specific changes include:
- EBITDA Definition: Revised to include specific add-back adjustments for one-time charges related to business integration ($250,000 cap) and facility moves ($250,000 cap), as well as lease buyout expenses with specific caps based on timing.
- Fixed Charge Coverage Ratio: Revised to define Maintenance Capital Expenditures as 50% of depreciation expense.
- Reporting Requirements: Financial statement delivery timelines were revised to require submission within 30 days of the end of each fiscal quarter, or within 30 days of the end of each calendar month if Revolving Loans are outstanding.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, revenue outlook, or management commentary regarding future business performance. The document focuses strictly on the terms of the credit facility amendment. Risks associated with the filing are limited to the Company's ability to comply with the revised financial covenants and the obligations under the new debt structure.
Key Facts for Investor Verification
- Verify the total available liquidity under the new $11,750,000 Revolving Commitment and the $10,000,000 Capital Expenditure Loan.
- Confirm the impact of the revised EBITDA add-backs on the Company's compliance with financial covenants.
- Review the full text of the Sixth Amendment to Credit Agreement (Exhibit 10.1) for detailed terms regarding the refinanced single Term Loan.
- Note that the filing does not contain current period revenue, net income, or cash flow data.